Mechanisms of resistance to EZH2 inhibitors in diffuse large B-cell lymphomas. - Abstract - Europe PMC
Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation | Nature Communications
A covalently bound inhibitor triggers EZH2 degradation through CHIP‐mediated ubiquitination | The EMBO Journal
Six Years (2012–2018) of Researches on Catalytic EZH2 Inhibitors: The Boom of the 2‐Pyridone Compounds - Fioravanti - 2018 - The Chemical Record - Wiley Online Library
UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition - ScienceDirect
GSK126 inhibits cellular EZH2 methyltransferase activity in multiple... | Download Scientific Diagram
Identification of EZH2 and EZH1 Small Molecule Inhibitors with Selective Impact on Diffuse Large B Cell Lymphoma Cell Growth - ScienceDirect
Pharmacological inhibition of EZH2 by GSK126 decreases atherosclerosis by modulating foam cell formation and monocyte adhesion in apolipoprotein E‑deficient mice
GSK126 | ≥99%(HPLC) | Selleck | Histone Methyltransferase inhibitor
Inhibitors of the Histone Methyltransferases EZH2/1 Induce a Potent Antiviral State and Suppress Infection by Diverse Viral Pathogens | mBio
A covalently bound inhibitor triggers EZH2 degradation through CHIP‐mediated ubiquitination | The EMBO Journal
Epigenetic‐Based Mechanisms of Osteoblast Suppression in Multiple Myeloma Bone Disease - Adamik - 2019 - JBMR Plus - Wiley Online Library
Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress | PNAS
Enhancer of Zeste Homolog 2 Inhibition Stimulates Bone Formation and Mitigates Bone Loss Caused by Ovariectomy in Skeletally Mature Mice* - Journal of Biological Chemistry
EZH2 - Wikipedia
Cancers | Free Full-Text | EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs) | HTML
GSK126 inhibits proliferation and causes G2/M cell cycle arrest in EZH2... | Download Scientific Diagram
Pharmacological inhibition of EZH2 by GSK126 decreases atherosclerosis by modulating foam cell formation and monocyte adhesion in apolipoprotein E‑deficient mice
GSK126 causes cell growth inhibition via de-repression of tumor... | Download Scientific Diagram
Pharmacological inhibition of EZH2 by GSK126 decreases atherosclerosis by modulating foam cell formation and monocyte adhesion in apolipoprotein E‑deficient mice
Catalytic Inhibitors of EZH2 Fail to Recapitulate the EZH2 Knockdown... | Download Scientific Diagram
Frontiers | EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice | Immunology
Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress | PNAS
Pharmacological inhibition of EZH2 combined with DNA‑damaging agents interferes with the DNA damage response in MM cells
EZH2 - Wikipedia
Diosgenin and GSK126 Produce Synergistic Effects on Epithelial–M | OTT
Identification and characterization of second-generation EZH2 inhibitors with extended residence times and improved biological activity - Journal of Biological Chemistry
